Skip to main content

Advertisement

SpringerLink
Log in

RISK FACTORS

Topical glucocorticoids and risk of type 2 diabetes mellitus

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

A positive association between topical corticosteroid use and risk of type 2 diabetes mellitus has been reported in a large European population-based study. However, the increase in risk is small and should not influence the prescribing of topical corticosteroids when clinically indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. National Institute for Health and Care Excellence. Clinical knowledge summaries. Corticosteroids — oral. NICE https://cks.nice.org.uk/corticosteroids-oral#!scenarioRecommendation:3 (2017).

  2. Andersen, Y. M. F. et al. Association between topical corticosteroid use and type 2 diabetes in two European population-based adult cohorts. Diabetes Care https://doi.org/10.2337/dc18-2158 (2019).

    Article  PubMed  Google Scholar 

  3. Reynolds, R. M. et al. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur. J. Endocrinol. 166, 861–868 (2012).

    Article  CAS  Google Scholar 

  4. Krejci-Manwaring, J. et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J. Am. Acad. Dermatol. 54, S235–S236 (2006).

    Article  Google Scholar 

  5. Lin, L.-K. et al. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res. Care 5, e000429 (2017).

    Article  Google Scholar 

  6. Donnelly, L. A., Morris, A. D. & Evans, J. M. M. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 100, 345–350 (2007).

    Article  CAS  Google Scholar 

  7. Leong, A. et al. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care 36, 3002–3008 (2013).

    Article  Google Scholar 

  8. Geer, E. B., Islam, J. & Buettner, C. Mechanisms of glucocorticoid-induced insulin resistance. Endocrinol. Metab. Clin. North Am. 43, 75–102 (2014).

    Article  CAS  Google Scholar 

  9. Hengge, U. R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54, 1–15 (2006).

    Article  Google Scholar 

  10. Milyani, A. A. & Al-Agha, A. E. Implication of topical steroids in the onset of osteoporosis. Case Rep. Pediatr. 2018, 4802172 (2018).

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tommy’s Centre for Maternal and Fetal Health, MRC Centre for Reproductive Health, University of Edinburgh, Queen’s Medical Research Institute, Edinburgh, UK

    E. C. Johns & R. M. Reynolds

  2. BHF Centre for Cardiovascular Science, University of Edinburgh, Queen’s Medical Research Institute, Edinburgh, UK

    R. M. Reynolds

Authors
  1. E. C. Johns
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. M. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. M. Reynolds.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johns, E.C., Reynolds, R.M. Topical glucocorticoids and risk of type 2 diabetes mellitus. Nat Rev Endocrinol 15, 379–380 (2019). https://doi.org/10.1038/s41574-019-0212-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-019-0212-8

  • Springer Nature Limited

This article is cited by

Search

Navigation